Ignite Creation Date:
2025-12-24 @ 11:02 PM
Ignite Modification Date:
2026-01-04 @ 9:51 PM
Study NCT ID:
NCT02324569
Status:
COMPLETED
Last Update Posted:
2023-12-12
First Post:
2014-12-19
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Phase 4, Randomized, Double-blind, Parallel-group, Comparative Study and a Phase 4, Open-label, Long-term Study of SYR-472 (100 mg) in Combination With Insulin in Patients With Type 2 Diabetes
Sponsor:
Takeda
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-12-27
Start Date Type:
ACTUAL
Primary Completion Date:
2016-12-28
Primary Completion Date Type:
ACTUAL
Completion Date:
2016-12-28
Completion Date Type:
ACTUAL
First Submit Date:
2014-12-19
First Submit QC Date:
None
Study First Post Date:
2014-12-24
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2017-12-27
Results First Submit QC Date:
None
Results First Post Date:
2019-02-11
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-12-07
Last Update Post Date:
2023-12-12
Last Update Post Date Type:
ACTUAL